2013 annual financial data
ADMA Biologics 2013 Operating cash flow margin
Direct answer
Operating cash flow margin was -354.91%.
Operating income was -15,042,431 USD and net income was -15,527,246 USD.
Operating cash flow was -10,887,154 USD.
Get free ADMA Biologics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,067,577 USD
- Operating income
- -15,042,431 USD
- Net income
- -15,527,246 USD
- Operating cash flow
- -10,887,154 USD